Dispatches from Vitafoods Europe 2014

Omega-3’s newest big fish reveals sector ambitions

This content item was originally published on www.nutraingredients.com, a William Reed online publication.

By Shane STARLING

- Last updated on GMT

Related tags Nutrition Docosahexaenoic acid Epax Dsm

Mid-last year the chief of Norwegian omega-3 player EPAX told us, “We are the last of the big omega-3 independents.” Soon after US agri-food company FMC had snapped it up for $350m. Here FMC Nutraceuticals general manager Daniel H. Rosenbaum talks through the ‘how’ and the ‘why’ of the move…and the ‘where’ it might lead.

“The opportunity to take a position in omega-3 – particularly a premium position – was really one that fit our growth ambitions quite well,” ​he said.

Rosenbaum discusses omega-3 formulation, regulation, science and more here and why it is looking to further invest in health and wellness.

The omega-3 sector has seen serious consolidation in recent years with acquisitions including Martek Biosciences (DSM, €830m), Ocean Nutrition Canada (DSM, €430m) and Pronova Biopharma (BASF, €690m).

Related news

Show more

Related products

show more

How to soothe pet with natural ingredients

How to soothe pet with natural ingredients

Ingredia SA | 06-Mar-2023 | Product Presentation

Stress rises for your pet, which may lead to destructive behaviors, barking, accidents in the house, skin, or gastrointestinal problems.
Lactium...

Magtein Application Data for Product Development

Magtein Application Data for Product Development

AIDP, Inc | 01-Mar-2023 | Application Note

Brain health and mental wellness are intertwined. Brain health products are no longer just for memory and focus and have expanded into related health segments...

Related suppliers

Follow us

Products

View more

Webinars